Comparison between Dipna Pharmachem IPO and EP Biocomposites IPO.
Dipna Pharmachem IPO is a SME Fixed Price IPO proposed to list at BSE SME while EP Biocomposites IPO is a SME Fixed Price proposed to list at BSE SME.
| Dipna Pharmachem IPO | EP Biocomposites IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sernet Financial Services Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dipna Pharmachem IPO is up to ₹14.43 Cr whereas the issue size of the EP Biocomposites IPO is up to ₹6.00 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of EP Biocomposites IPO is ₹126.00 per share.
| Dipna Pharmachem IPO | EP Biocomposites IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹38.00 per share | ₹126.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1000 shares |
| Fresh Issue Size | 37,98,000 shares | 4,76,000 shares |
| Fresh Issue Size (Amount) | up to ₹14.43 Cr | up to ₹6.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 37,98,000 shares | 4,76,000 shares |
| Issue Size Total (Amount) | up to ₹14.43 Cr | up to ₹6.00 Cr |
Dipna Pharmachem IPO opens on Aug 25, 2022, while EP Biocomposites IPO opens on Aug 29, 2022. The closing date of Dipna Pharmachem IPO and EP Biocomposites IPO is Aug 30, 2022, and Sep 05, 2022, respectively.
| Dipna Pharmachem IPO | EP Biocomposites IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2022 | Aug 29, 2022 |
| Issue Close | Aug 30, 2022 | Sep 05, 2022 |
| Basis Of Allotment (Tentative) | Sep 08, 2022 | |
| Initiation of Refunds (Tentative) | Sep 09, 2022 | |
| Credit of Share (Tentative) | Sep 12, 2022 | |
| Listing date (Tentative) | Sep 08, 2022 | Sep 13, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dipna Pharmachem IPO P/E ratio is 39, as compared to EP Biocomposites IPO P/E ratio of 26.2.
| Dipna Pharmachem IPO | EP Biocomposites IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 98.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.56 | 69.40 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39 | 26.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹45.49 Cr. | ₹21.19 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹333.40 | ₹9.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 67.12 | 40.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dipna Pharmachem IPO Retail Individual Investors (RII) are offered 18,99,000 shares while in EP Biocomposites IPO retail investors are offered 18,99,000 shares. Qualified Institutional Buyers (QIB) are offered in Dipna Pharmachem IPO and in EP Biocomposites IPO.
| Dipna Pharmachem IPO | EP Biocomposites IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,04,000 shares | 28,000 shares |
| QIB | ||
| NII | 18,99,000 shares | 2,38,000 shares |
| RII | 18,99,000 shares | 2,38,000 shares |
| Employee | ||
| Others | ||
| Total | 37,98,000 shares | 4,76,000 shares |
Dipna Pharmachem IPO subscribed 2.77x in total, whereas EP Biocomposites IPO subscribed 18.51x.
| Dipna Pharmachem IPO | EP Biocomposites IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.78x | 21.58x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.75x | 15.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.77x | 18.51x |
